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Abstract
Background: The physiological fall in haemoglobin concentration from the 1st to the 3rd trimester of pregnancy is
often quoted as 5 g/L. However, other studies have suggested varying levels of fall between 8 and 13 g/L. We
evaluated the change in haemoglobin concentration between the 1st and 3rd trimesters of pregnancy in a multi-
ethnic population of pregnant women.
Methods: A retrospective cohort analysis of 7054 women with singleton pregnancies, giving birth during 2013–15
in a single urban maternity unit in England.
We calculated the changes in haemoglobin concentration from 1st to 3rd trimester using the first trimester
haemoglobin as the reference point. The population was stratified into sub-groups to explore any differences
that existed within the population.
Results: In general the fall in haemoglobin concentration was in the order of 14 g/L or 11% of the first
trimester value. This fall was consistent for the majority of sub-groups of the population. The fall was lower
(7.7%) in the most deprived section of the population, IMD1, but it increased to 11.7% when we restricted
that sub-group to pregnant women without health problems during the index pregnancy. Conversely, there
was an increase in haemoglobin of 10.2% in women whose first trimester haemoglobin concentration was in
the lowest 5% of the total study population. The population fall in haemoglobin was 10.2 g/L (7.8%), after
excluding cases above the 95th and below the 5th centiles, and women with a medical and/or obstetric
disorder during the pregnancy.
Conclusion: The fall in haemoglobin during pregnancy is in the order of 14 g/L or 11% of the first trimester
level. This is 2 to 3 times higher than suggested by some guidelines and higher than previously published
work. The results challenge the current accepted thresholds for practice, and have broader implications for
diagnosis and managment of antenatal anaemia.
Tweetable abstract: Fall in haemoglobin across pregnancy is around 14 g/L (11%) and significantly higher
than previously stated in the pregnant population. This poses questions over currently accepted thresholds for
anaemia in pregnancy.
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Background
It is commonly stated that during pregnancy, the physio-
logical fall in haemoglobin concentration (Hb) is approxi-
mately 5 g/L. This finding has been based upon changes
to the lower 5th centile of haemoglobin concentration
between the first and third trimesters and established
guidelines that include Hb thresholds for diagnosisng iron
deficiency anaemia in pregnancy [1–3]. Some older studies
have derived reference curves from other published data,
while others have charted the changes and found falls in
haemoglobin concentration ranging between 8 to 13 g/L.
But, these studies are often limited to a highly selected
small samples of pregnant women [4–10].
The pregnancy related fall in the haemoglobin concen-
tration across gestation is in the main due to the in-
crease in plasma volume exceeding the increase in red
cell mass [11]. However, the understanding of the
physiological processes that influence these changes dur-
ing pregnancy are still incomplete [12, 13]. Nevertheless,
the change of 5 g/L is reflected in many guidelines,
which state the threshold for the diagnosis of anaemia in
the second and third trimesters should be lowered from
110 g/L to 105 g/L.
Understanding the changes in haemoglobin concentra-
tion is important clinically. The current thresholds for
diagnosing iron deficiency anaemia (IDA) in pregnancy
attempt to account for the fall in haemoglobin. Even a
diagnosis of mild anaemia, will result in treatment with
iron, which itself causes significant troublesome side ef-
fects for many pregnant women [14, 15].
However, our previous work has shown a significant
increase in mortality and morbidity from moderate to
severe anaemia, in particular, a 3 to 5-fold increased risk
of stillbirth [16, 17]. Therefore, even in high income
countries, true iron deficiency anaemia in pregnancy is a
significant risk factor for poor obstetric outcomes and
warrants detection and effective treatment.
Aims
The aims of this study were first, to re-evaluate the re-
duction in haemoglobin between the first and third tri-
mesters in a large multi-ethnic population of pregnant
women. Second, to explore any differences in the degree
of fall of haemoglobin in differing sub-groups by stratify-
ing the population.
Methods
We conducted a retrospective cohort analysis using ma-
ternity data of all women (n = 7054), with singleton preg-
nancies receiving maternity care at The Royal
Wolverhampton NHS Trust between 2013 and 2015.
This multi-ethnic population in the English midlands
has high levels of deprivation. Deprivation was quanti-
fied using the Department for Communities and Local
Government, English Indices of Deprivation 2015; the
Index of Multiple Deprivation (IMD) which combines
seven domains of deprivation; income, employment,
education skills and training, health and disability, crime,
barriers to housing and services, and living environment.
Information on maternal haemoglobin at the first tri-
mester ‘booking’ visit, median 10 weeks’ gestation, and
the 28-week visit was extracted from the hospital path-
ology system and then manually paired with the
woman’s corresponding maternity dataset. The single
dataset was then de-identfied (anonymised) by removing
all personal identifiers, names, dates of birth, hospital
numbers, address and postcode.
Our study data included factors known or thought to
have a significant influence on haemoglobin concentra-
tion. These were ethnicity, haemoglobinopathy genotype,
BMI, maternal age; hypertensive disorders of pregnancy,
antepartum haemorrhage, low socioeconomic status
(measured using IMD quintiles) and other medical
comorbidities such as renal diseases, diabetes, chronic
essential and secondary hypertension.
Maternal records relating to problems during the index
pregnancy were used to generate binary variables for ante-
partum haemorrhage, gestational diabetes and hyperten-
sive disorders of pregnancy. Three binary variables were
generated from the history of medical co-morbidities -
pre-existing haemoglobinopathies, pre-existing diabetes
mellitus and any other medical comorbidities (excluding
obesity).
The total study population was then stratified into sub-
groups based on i) the distribution of haemoglobin con-
centration in the first trimester (less than 5th centile, 5th
to 95th centile, >95th centile), ii) ethnicity, iii) socioeco-
nomic status (IMD quintiles), iv) presence of haemo-
globinopathy trait, and v) body mass index (BMI). Each
sub-group was then refined further to eliminate the effects
of specific population characteristics that may influence
the change in Hb concentration. For example, women
with a pre-existing medical disorder, or who developed an
obstetric disorder such as pre-eclampsia, known to be as-
sociated with reduced plasma volume expansion,
or women who were anaemic in the first trimester, and
women with a ferritin level < 30 micrograms/L, and < 15
micrograms/L (in two separate sub-group analyses) all are
more likely to be prescribed iron preparations. Non-
clinical factors may also affect the change in haemoglobin
concentration e.g. socioeconomic deprivation is associ-
ated with a poor diet and chronic nutritional deficiencies
of iron, vitamin B12 or folic acid.
In addition, outliers below the 5th and above the 95th
centiles of Hb in the first trimester were excluded from
the main study population, but were investigated as sub-
groups on their own in the same way as we have de-
scribed above.
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Statistical analyses
We examined the distribution of first and third trimester
haemoglobin concentration in the study population and
corrected skewedness by removing the outliers to ensure
a normal distribution around the mean. We then calcu-
lated the mean, standard deviation, inter-quartile ranges
and 5th to 95th centiles for haemoglobin concentration
in the first and third trimesters. We calculated absolute
and percentage change in mean haemoglobin relative to
the first trimester Hb. We conducted all of the above-
mentioned analyses in the total population and in each
population sub-group. All analyses were performed
using Stata version 15.1, SE (StataCorp, College Station,
TX).
Ethics committee approval was not required as this
was a secondary analysis of anonymous/de-identified
and routinely available hospital data.
Results
The fall in mean haemoglobin concentration, for the
whole population, from the first to third trimester was
14.2 g/L and was consistently in the region of 14 g/L or
11% of the first trimester haemoglobin concentration in
the majority of sub-groups. The exceptions were women
who fell below the 5th population centile in the first tri-
mester. They had an increase in haemoglobin concetra-
tion of 10%; women who were above the 95th
centile had a fall in haemoglobin of 26.6 g/L (18%) and
women falling between the 5th and 95th centiles who
had no co-morbid condition a fall of 10.2 g/L (7.8%)
(Table 1). Women with a haemoglobinopathy trait, alpha
/ beta thalassaemia or a sickle cell variant also had a
lower fall in haemoglobin of 9 g/L (7.7%). Adjusting
the sub-groups of women stratified by their IMD rank
by quintile made no material difference to the level of
fall in haemoglobion which was 13 g/L. Similarly stratify-
ing by body mass index made no difference to the level
of fall. Finally ethnicity appeared to have little effect, al-
though Blacks (women of African or Caribbean origin)
had a slightly smaller fall of 11.9 g/L (9.8%), but their
were considerably fewer women than in the other ethnic
groups (Table 2).
By using two thresholds of ferritin to represent true
iron deficiency in pregnancy and excluding women with
low first trimester ferritin levels in Subgroup A (ferritin
≤30mcg/L) and Subgroup B (ferritin ≤15mcg/L) there
was still consistency with our overall results with an 11.4
and 11.7% fall in haemoglobin in the respective groups.
Notably women in the most deprived IMD quintile
had a fall in haemoglobin concentration of 9 g/L (7.7%)
but the change in concentration increased to 15.1 g/L
(11.7%) when we excluded women with obstetric and
medical co-morbidities.
Discussion
The findings of this study indicate that the fall in
haemoglobin concentration during pregnancy appears
to be much greater than often described in guidelines,
and is of the order of 14 g/L from the first trimester
level. This result should be considered in the light of
a long history of defining thresholds of haemoglobin
for health and disease using selected samples of “nor-
mal” pregnant women. The definition of anaemia in
pregnancy used by many was first reported by the
World Health Organisation 50 years ago [3], in which
the lower limit of normal for pregnancy was set at
110 g/L. Interestingly, the report recognised that al-
though these reference standards were needed, they
Table 1 Total population changes in haemoglobin concentration between the first and 3rd trimesters and stratified sub-groups by
distribution of haemoglobin
1st Trimester Hb 3rd Trimester Hb
Sample N mean SD IQ 5/95% N mean SD IQ 5/95% ΔHB(%)
Total Population 7054 127.9 11.2 121–134 108/143 6642 113.7 10.3 107–121 96/130 −14.2(11)
Population 5th- 95th centile 6078 127.0 7.9 122–133 5745 113.0 9.5 117–120 −14.4 (11.3)
Subgroup A ƒ 4224 130 8.8 124–136 116/144 4028 115.6 9.2 110–122 101/131 −14.4 (11.0)
Subgroup B ƒƒ 5876 129.4 8.8 123–135 115/144 5476 114.7 9.6 109–121 99/130 −14.7(11.4)
Subgroup C 5th -95th centile &a 1958 128.1 7.86 123–134 115/140 1855 114.2 9.4 108–121 98/129 −13.9(10.9)
Subgroup D 5th–100th centile &a 2103 129.4 9.18 123–136 114/144 2035 114.8 9.75 109–121 98/130 −14.6(11.3)
Subgroup E = < 5 centile &a 78 98.7 9.59 95–106 74/107 57 108.8 12.7 99–119 89/128 + 10.1(10.2)
Subgroup F 5th–95th centile &a 1303 130 7.0 126–136 118.141 1303 118 6.2 114–123 110/130 −10.2 (7.8)
Subgroup EG > 95th centile &a 145 147.8 5.07 144–149 1143/158 180 121.2 11.03 114–137 103/137 −26.6(18.0)
ΔHB(%) – represents the absolute change in haemoglobin and the percentage change in brackets
Each subgroup represents the total population excluding the women as shown by the symbols below
a Restricting the sample to pregnant women without the following problems during index pregnancy current pregnancy problems, pregnancy induced
hypertension, Pre-term birth, antepartum haemorrhage, pre-pregnancy med problems, diabetes, hypertension, renal disease, & anaemia in 1st trimester
ƒ excludes anaemic women and women with a serum ferritin <30mcg/L in the first trimester
ƒƒexcludes anaemic women and women with a serum ferritin <15mcg/L in the first trimester
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were also “somewhat arbitrary”. The limitations of the
methods used for defining anaemia have been detailed
over the years, but specific to pregnancy was the fail-
ure in the WHO system to account for the normal
physiological changes of the maternal cardiovascular
and haematological systems. This effect was acknowl-
edged in a later report and by the Centre for Disease
Control and Prevention in the USA, that stated the
haemoglobin concentration in pregnancy could fall by
5 g/L due to plasma volume expansion [2]. Other
bodies recognised this and incorporated the effect in
their guidance. In the British Sociey of Haematology
guidelines, the lower limit of normal for haemoglobin
is stated to be 110 g/L in the first trimester, 105 g/L
in the second and third trimesters and 100 g/L in the
puerperium, the latter to account for the blood loss
of childbirth [1].
The physiological changes that take place in the cardio-
vascular and haematological systems during pregnancy
have been extensively researched. The increase in plasma
volume from the first to the third trimester is between
1100 - 1250mls, which is an increase in the total blood
volume of between 40 to 50% [18]. In contrast, technical
difficulties have limited establishing more accurate mea-
sures of red cell mass changes during pregnancy [13]. It is
currently estimated that the increase in iron replete
women is 250mls, but in women taking iron supplements
the increase can be as much as 400mls. This in itself sig-
nificantly alters the haemoglobin concentration and the
range of haemoglobin at different gestations when com-
pared with women not taking iron supplements [10]. The
sum effect on haematocrit from these changes is a fall
from 40 to 33%, with the nadir between 24 to 32 weeks’
gestation. What is known is that the physiological changes
in plasma volume and red cell mass will inevitably alter
the measured concentration of haemoglobin and have to
be taken into account when assessing the risk ascribed to
a pregnancy from ‘anaemia’.
Our study suggests that the fall in Hb concentration
from the first to the third trimester could be as much
as two to three times higher than the 5 g/L fall
accounted for in the guidelines when defining the lower
Table 2 Total population changes in haemoglobin concentration between the first and 3rd trimesters and stratified sub-groups
by ethnicity, deprivation and body size as represented by the body mass index (BMI). ΔHB(%) – represents the absolute change in
haemoglobin and the percentage change in brackets
1st Trimester Hb 3rd Trimester Hb
Sample N mean SD IQ 5/95% N mean SD IQ 5/95% ΔHB(%)
Total Population 7054 127.9 11.2 121–134 108/143 6642 113.7 10.3 107–121 96/130 −14.2(11)
South Asians a 1097 123.4 10.9 117–130 104/140 1042 110.8 11.13 104–119 93/128 −12.6(10.2)
Blacks a 294 121.5 11.4 115–129 102/139 274 109.6 9.77 104–116 93/125 −11.9(9.8)
Mixeda 76 127.8 8.53 122–133 113/142 74 111.0 8.48 105–118 97/125 −16.8(13.4)
White a 4405 129 10.6 123–136 112/144 4191 114.9 9.81 109–121 98/131 −14.1(10.9)
Subgroup H b 5663 128 10.3 122–135 111/144 5298 114 9.8 108–121 98/130 −14(10.9)
Subgroup I c 728 117 12.7 109–126 95/136 676 108 12.1 100–116 88/128 −9(7.7)
IMD Q1 (most deprived) 3957 126 11.3 120–134 107/143 3720 112.8 10.5 106–120 95/129 −9(7.7)
IMD Q2 1074 126.9 11.7 122–134 107/143 1011 113.7 10.2 108–120 96/130 −13.2(10.4)
IMD Q3 778 128 10.1 122–135 110/144 739 115 9.8 109–121 99/131 −13(10.1)
IMD Q4 741 128 10.7 122–135 111/144 695 115.5 9.7 109–122 99/131 −12.5(9.8)
IMD Q5 (least deprived) 455 128.5 10.5 123–135 114/144 438 115.7 9.2 110–121 101/131 −12.8((9.3)
IMD Q1 a 1037 128.9 9.06 123–135 114/144 1008 113.8 9.79 108–121 97/129 −15.1(11.7)
IMD Q2&3 a 4273 126.6 11.27 120–134 107/143 4025 112.9 10.49 106–120 95/129 −13.7(10.8)
IMD Q 4&5 a 918 128.6 10.4 123–135 111/144 871 115.6 9.49 109–122 100/131 −13(10.1)
BMI Obese 1711 128.8 10.8 123–136 110/145 1604 115.8 9.8 110–122 99/132 −13(16.7)
BMI Underweight 231 124.5 10.9 117–132 107/141 222 110.5 11.5 104–117 89/128 −14(17.3)
BMI normal+overweight 4946 126.5 11.2 121–134 107/143 4678 113.1 10.3 107–120 96/129 −13.4(16.9)
IMD1 excluding obese 2832 125.8 11.4 120–133 106/142 2679 111.9 10.6 105–119 94/129 −13.9 (17.4)
Each subgroup represents the total population excluding the women as shown by the symbols below
a Restricting the sample to pregnant women without the following problems during index pregnancy current pregnancy problems, pregnancy induced
hypertension, Pre-term birth, antepartum haemorrhage, pre-pregnancy med problems, diabetes, hypertension, renal disease, & anaemia in 1st trimester
b women without a haemoglobinopathy trait
c Women with an haemoglobinopathy trait
IMD = Index of multiple deprivation
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limit of normality in pregnancy. Our data identified
a mean fall in haemoglobin concentration consistently in
the order of 14 g/L or 11% of the first trimester haemo-
globin. It was also greater than the other studies that
attempted to define reference ranges during pregnancy.
Some studies derived curves from reported figures and
all tended to be on small, highly selected samples of
women deemed to be ‘normal’ during pregnancy [6–10].
Stratification of the population was designed to evalu-
ate sub-groups characterised by factors known to be
directly or indirectly associated with changes in the
haemoglobin concentration. For example, body mass
index (BMI) is also positively correlated with haemoglo-
bin, ethnicity has effects through haemoglobinopathy
traits and social deprivation is more likely to be associ-
ated with poor nutrition and/or co-existing chronic
medical diseases, both risk factors for anaemia. We used
the IMD as a measure of deprivation, which in it’s 7 do-
mains also accounts for nutrition and health, but also
other factors that have a direct bearing upon both of
these such as income and housing etc.
The sub-groups were refined further by the removal of
pregnancy complications/conditions that could lead to
attenuation of the changes in plasma volume and thus
the change in haemoglobin across the trimesters. Even
after excluding women with pregnancy induced hyper-
tension, pre-term birth, antepartum haemorrhage, and
pre-pregnancy medical problems, diabetes, hypertension,
renal disease, and anaemia in first trimester, we found
remarkable consistency in the fall in haemoglobin con-
centration between the total population and the majority
of the subgroups.
The precise reasons for different levels of fall in
haemoglobin concentration for some groups of women
is not known, but may have implications for clinical
practice. Women in the most deprived sub-group, IMD1
may have been unduly influenced by factors such as pre-
existing medical disorders. When we removed women
with medical disorders, including anaemia in the first tri-
mester as a factor, the fall in this group became larger
15.1 g/L (11.7%). Alternatively, other indirect factors
could have had an influence in this group. In the most
socio-economically deprived group of our population
the reduced fall in haemoglobin may reflect a poor diet,
and so a greater likelihood of being prescribed oral iron
either prophylactically or therapeutically.
Finally, we assessed whether there was an effect on fall
of haemoglobin by evaluating the differences for two
common diagnostic thresholds of level of ferritin,
30mcg/L and 15mcg/L for iron-deficeincy. There was no
effect on different degrees of fall in haemoglobin, which
supports the view that in pregnancy, ferritin is not useful
when trying to assess the level of iron deficiency that re-
quires treatment [19].
From the population distribution, women above the
95th percentile, of the population had much greater falls
in haemoglobin; 26.6 g/L(18.0%). The explanation for
this finding is unclear, but it might potentially indicate
some, as yet unknown, homeostatic mechanism for
plasma volume expansion to ensure that the blood vis-
cosity does not impede flow through the placental
vasculature.
Body mass index (BMI) did not appear to make a dif-
ference with each of the three categories, obese, under-
weight and normal plus overweight all having a very
similar falls in haemoglobin concentration.
The limitations of our study should be acknowledged.
The data are derived from a single site and from a
multi-ethnic population in the industrial heart of the
English midlands. Therefore, there is the potential for
some local effects that may affect the findings, although
the consistency of the findings after stratification sug-
gests that any such effect is probably limited. Some cat-
egories of our subgroups contain small number of
women, although the variations around the mean are in
the main consistent. Nevertheless there remains uncer-
tainty around the findings for these sub-groups.
Conclusion
The results of this study have several implications. They
indicate that the fall in mean Hb and its distrubution
from the first to third trimester of pregnancy may be
nearly 3 times higher (14 g/L), than the currently quoted
figure of 5 g/L, which in turn determines the second and
third trimester threshold for the diagnosis of anaemia
during pregnancy. Our findings therefore, question the
level of the lower limit of normal for haemoglobin for
the diagnosis of iron deficiency anaemia in pregnancy.
There is a broad literature on the level at which the
haemoglobin concentration indicates increased risk of
adverse obstetric outcome. But one large population
study from London suggested that ‘mild anaemia’, be-
tween 9 and 11 g/L had the lowest rate of perinatal
mortality [20]. However, perinatal mortality is only
one of many adverse outcomes both maternal and
fetal, that are associated with anaemia. Applying a
threshold approach based upon an expected quoted
fall of 5g/L, as reported in some guidelines, may be
an over-simplification. Our earlier published work has
also shown an inverse linear relationship between the
level of haemoglobin in the first trimester and still-
birth [16]. Taken in conjunction with the findings of
this study, there is a need for robust epidemiological
data matching the level of haemoglobin to outcome
for both the fetus and mother so that appropriate ad-
vice to women on the prevention or treatment of an-
aemia can then be offered with more precision and
confidence.
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